Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 8/20 | 0.47 |
| ▸ | SELL | P14151 | 3/20 | 0.36 |
| ▸ | SELE | P16581 | 3/20 | 0.36 |
| ▸ | PYGB | P11216 | 1/20 | 0.36 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | IGF2R | P11717 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25249456 | 1.00 | SELP (0.47) | SELPSELLSELEPYGBSYNJ2 | |
| SCHEMBL25292722 | 1.00 | SELP (0.47) | SELPSELLSELEPYGBSYNJ2 | |
| SCHEMBL2792360 | 1.00 | SELP (0.47) | SELPSELLSELEPYGBSYNJ2 | |
| SCHEMBL3291690 | 0.91 | SELP (0.52) | SELPPYGBSYNJ2IGF2R | |
| SCHEMBL3292702 | 0.91 | SELP (0.52) | SELPPYGBSYNJ2IGF2R | |
| SCHEMBL25290351 | 0.84 | SELP (0.46) | SELPSELLSELEPYGBIGF2R | |
| SCHEMBL2791567 | 0.84 | SELP (0.46) | SELPSELLSELEPYGBIGF2R | |
| SCHEMBL25256090 | 0.84 | SELP (0.46) | SELPSELLSELEPYGBIGF2R | |
| SCHEMBL2790055 | 0.84 | SELP (0.46) | SELPSELLSELEPYGBIGF2R | |
| SCHEMBL25292780 | 0.82 | LGALS1 (0.40) | SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7862804-B2 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | LOREAL (FR) | 2011-01-04 | — | — | US | claimed |
| EP-1774990-B1 | Use of c-glycosides for depigmenting skin | OREAL (FR) | 2009-12-09 | — | — | EP | claimed |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | L'OREAL (FR) | 2007-04-12 | — | — | US | claimed |
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | claimed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | claimed |
| CN-102348450-B | Product for preventing or treating hair graying | 欧莱雅 | 2016-11-09 | — | — | CN | disclosed |
| US-9421157-B2 | Use of C-glycoside derivatives as pro-desquamating active agents | L'OREAL (FR) | 2016-08-23 | — | — | US | disclosed |
| WO-2013088368-A2 | USE OF THE MMP-12 PROTEIN IN THE PREVENTION AND/OR TREATMENT OF AGED OR SENESCENT SKIN | L'OREAL (FR) | 2013-06-20 | — | — | WO | disclosed |
| US-8445459-B2 | Combination of monosaccharide with C-glycoside derivative and use thereof | L'OREAL (FR) | 2013-05-21 | — | — | US | disclosed |
| US-7862804-B2 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | LOREAL (FR) | 2011-01-04 | — | — | US | disclosed |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | L'OREAL (FR) | 2010-07-29 | — | — | US | disclosed |
| US-20100168055-A1 | COMBINATION OF MONOSACCHARIDE WITH C-GLYCOSIDE DERIVATIVE AND USE THEREOF | L'OREAL (FR) | 2010-07-01 | — | — | US | disclosed |
| WO-2008004165-A2 | USE OF C-GLYCOSIDE DERIVATIVES AS PRO-DESQUAMATING ACTIVE AGENTS | L'OREAL (FR) | 2008-01-10 | — | — | WO | disclosed |
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | L'OREAL S.A. (FR) | 2008-01-10 | — | — | US | disclosed |
| US-20080008674-A1 | Use of C-glycoside derivative for improving the skin's barrier function | L'OREAL (FR) | 2008-01-10 | — | — | US | disclosed |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | L'OREAL (FR) | 2008-01-03 | — | — | US | disclosed |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | L'OREAL (FR) | 2007-04-12 | — | — | US | disclosed |
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL S.A. (FR) | 2006-10-05 | — | — | US | disclosed |
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | disclosed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | DSG1, TYR, CUTA | SELP 1538/4885SELL 2652/4885SELE 2961/4885 |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | TYR, CAT, NQO1 | SELP 1067/4885SELL 2555/4885SELE 1539/4885 |
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | SELP 563/4885SELL 367/4885SELE 629/4885 |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | GLA, CD44, FUT6 | SELP 3075/4885SELL 1655/4885SELE 3003/4885 |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | SELP 563/4885SELL 367/4885SELE 629/4885 |
| US-20080008674-A1 | Use of C-glycoside derivative for improving the skin's barrier function | CUTA, UGCG, GLA | SELP 780/4885SELL 2416/4885SELE 1996/4885 |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | CUTA, UGCG, PSAP | SELP 294/4885SELL 2457/4885SELE 2140/4885 |
| US-20100168055-A1 | COMBINATION OF MONOSACCHARIDE WITH C-GLYCOSIDE DERIVATIVE AND USE THEREOF | UGCG, FUT6, MANBA | SELP 482/4885SELL 741/4885SELE 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.